CAS: 4333-19-1; 5-Methyl-3-Phenyl-2-Thioxoimidazolidin-4-One

该化合物是一个环球化合物,其特点是其异氨基聚氨酯结构,包括一种三氧化硫(硫磺原子双壳,碳原子双壳)和一种甲基和苯基替代成分.这种化合物通常具有中等溶解性等特性,并由于存在可参与各种化学反应,包括核生殖器攻击的异氧联苯醚组而具有潜在的再活动性. 基聚酮框架有助于其稳定性,并可能影响其生物活动,使其对医药化学感兴趣. 此外,该苯基组的存在可增强脂性,并有可能影响其药用皮肤病特性.

结构式图片

相似化合物

4333-20-4 2010-15-3 7390-20-7

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号701-73-5 METHYL DITHI°CA... | CAS号302-72-7 DL-2-氨基丙酸 | CAS号103-72-0 异硫氰酸苯酯 | CAS号104892-42-4 N-phenylthi°Car... | CAS号17344-99-9 2-amino-propion... | CAS号75-15-0 二硫化碳 | CAS号74-88-4 碘甲烷 | CAS号7783-06-4 硫化氢 | CAS号302-72-7 DL-2-氨基丙酸

合成工艺路线路线简述

  • 合成目标产物 Phenylthiohydantoin-Dl-Alanine 主要起始原料 Ethanamine, N-[(3,5-Dichlorophenyl)Methylene]-2,2-Diethoxy-
  • (文献来源)合成步骤主要原料 Ethanamine, N-[(3,5-Dichlorophenyl)Methylene]-2,2-Diethoxy-
📜N-Phenylthiocarbamoyl-Dl-Alanine置于盐酸体系中,用 1,4-二氧六环,水 作为反应溶剂,化学反应 0.03H,以1.34 G的收率获得产物苯基硫代乙内酰脲-丙氨酸
参考文献:氨基脲脱水环化微波辅助合成1,3,4-恶二唑/硫代乙内酰脲杂化衍生物
标题:氨基脲脱水环化微波辅助合成1,3,4-恶二唑/硫代乙内酰脲杂化衍生物
摘要:E-Mail: Ydgong@dongguk.Edu 2014 年 7 月 29 日收到,2014 年 9 月 16 日接受 合成了一系列含有 1,3,4-恶二唑和硫代乙内酰脲的化合物,作为一种有前途的药物化学支架.合成的关键步骤是使用 Pocl 对在一个酰基末端具有硫代乙内酰脲部分的氨基脲进行微波辅助环化
DOI:10.5012/bkcs.2014.35.12.3609

海关参考信息

专利信息


专利号:US-6090250-A
优先权日:1993-09-20
标题 :Chiral surfactants and methods for their use in chiral separations
发明人:MAZZEO JEFFREY R; GROVER EDWARD R; SWARTZ MICHAEL E; MERION MICHAEL; PETERSEN JOHN S
权利人:WATERS INVESTMENTS LTD
摘要:PCT No. PCT/US94/10655 Sec. 371 Date Mar. 20, 1996 Sec. 102(e) Date Mar. 20, 1996 PCT Filed Sep. 20, 1994 PCT Pub. No. WO95/08529 PCT Pub. Date Mar. 30, 1995Chiral surfactants, methods for their synthesis and use, and apparatus designed to facilitate chiral separations using nucellar capillary electrophoresis is disclosed. A chiral surfactant having the general formula: is described, R1 is the hydrophobic tail, Y-A-X is the linker, the brackets define a chiral center, and the hydrophilic head group is Z. All the various components may potentiate the enantioselectivity of the chiral surfactant. The capillary electrophoresis (CE) system includes a narrow diameter capillary, a high voltage power supply, an electrolyte reservoir at each end of the capillary, a means for injecting a sample, and a detector. Chiral surfactants are dissolved in the electrolyte above their critical micelle concentration (cmc), resulting in the formation of chiral micelles. The electrolyte reservoirs and capillary tube are filled with the electrolyte. A sample containing a mixture of enantiomers is then injected into the capillary, and a high voltage potential is applied across the capillary. The sample components migrate through the capillary due to the influence of the applied electric field. An example separation of the four sereoisomers of aspartame is shown.

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Farmatsevtichnii Zhurnal, 17(1)(36), 1962
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知